Immunogenicity And Safety Of An Alum-Adjuvanted Inactivated H7N9 Influenza Vaccine
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 16 Nov 2018
At a glance
- Drugs H7N9 influenza vaccine-Shanghai Institute Of Biological Products (Primary)
- Indications Influenza A virus H7N9 subtype
- Focus Adverse reactions
- 09 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Nov 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Jan 2019.
- 18 Apr 2018 Status changed from not yet recruiting to recruiting.